These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2125796)

  • 1. Reversibility of canthaxanthin deposits within the retina.
    Leyon H; Ros AM; Nyberg S; Algvere P
    Acta Ophthalmol (Copenh); 1990 Oct; 68(5):607-11. PubMed ID: 2125796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canthaxanthin retinopathy. Anatomic and functional reversibility.
    Harnois C; Samson J; Malenfant M; Rousseau A
    Arch Ophthalmol; 1989 Apr; 107(4):538-40. PubMed ID: 2495787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carotinoid deposits in the retina].
    Philipp W
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):439-40. PubMed ID: 3936971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carotinoid retinopathy. III. Reversibility].
    Weber U; Goerz G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):20-2. PubMed ID: 3959472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carotenoid retinopathy. I. Morphologic and functional findings].
    Weber U; Goerz G; Hennekes R
    Klin Monbl Augenheilkd; 1985 May; 186(5):351-4. PubMed ID: 4021422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Canthaxanthin retinopathy].
    Nijman NM; Oosterhuis JA; van Bijsterveld OP; Baart de la Faille H; Suurmond D
    Klin Monbl Augenheilkd; 1989 Jan; 194(1):48-51. PubMed ID: 2496261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [En pailettes d'or maculopathy caused by carotinoid therapy].
    Hübner U; Frühauf A; Barth J
    Dermatol Monatsschr; 1986; 172(3):177-8. PubMed ID: 3084313
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin.
    Goralczyk R; Buser S; Bausch J; Bee W; Zühlke U; Barker FM
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):741-52. PubMed ID: 9071228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Canthaxanthin retinopathy without intake of canthaxanthin].
    Oosterhuis JA; Remky H; Nijman NM; Craandijk A; de Wolff FA
    Klin Monbl Augenheilkd; 1989 Feb; 194(2):110-6. PubMed ID: 2497265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis.
    Daicker B; Schiedt K; Adnet JJ; Bermond P
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):189-97. PubMed ID: 3111944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystalline retinopathy in patients taking an oral drug containing canthaxanthine.
    Ros AM; Leyon H; Wennersten G
    Photodermatol; 1985 Jun; 2(3):183-5. PubMed ID: 3927272
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application.
    Weber U; Kern W; Novotny GE; Goerz G; Hanappel S
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):198-205. PubMed ID: 3111945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of beta-carotene in combination with canthaxanthin, Ro 8-8427 (Phenoro), in treatment of polymorphous light eruptions.
    Suhonen R; Plosila M
    Dermatologica; 1981; 163(2):172-6. PubMed ID: 6793418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retinopathy due to canthazanthine: 2. Predisposing factors].
    Cortin P; Boudreault G; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1984 Aug; 19(5):215-9. PubMed ID: 6434169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral retinal dystrophy following administration of canthaxanthin?].
    Hennekes R
    Fortschr Ophthalmol; 1986; 83(5):600-1. PubMed ID: 3098656
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gold-dust maculopathy after absorption of canthaxanthine].
    Saraux H; Laroche L
    Bull Soc Ophtalmol Fr; 1983 Nov; 83(11):1273-4, 1277. PubMed ID: 6437691
    [No Abstract]   [Full Text] [Related]  

  • 17. [Canthaxanthin retinopathy and macular pucker--clinical picture and ultrastructural findings of macular pucker].
    Bopp S; el-Hifnawi E; Laqua H
    Fortschr Ophthalmol; 1989; 86(5):456-60. PubMed ID: 2511128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of beta-carotene and canthaxanthin during and after stopping intake of a combined preparation.
    Meyer JC; Grundmann HP; Seeger B; Schnyder UW
    Dermatologica; 1985; 171(2):76-81. PubMed ID: 3930305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Static perimetry in canthaxanthin maculopathy.
    Harnois C; Cortin P; Samson J; Boudreault G; Malenfant M; Rousseau A
    Arch Ophthalmol; 1988 Jan; 106(1):58-60. PubMed ID: 3122712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-carotene treatment of protoporphyrias and polymorphic light dermatoses].
    Barth J; Fickweiler E; Harnack K; Herrmann K; Hübner U; Schaarschmidt H; Schiller F
    Dermatol Monatsschr; 1984; 170(4):244-8. PubMed ID: 6428940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.